Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Pollen Allergenic Extract [EPC]
Bassia Scoparia Fruit is a non-standardized allergenic extract used primarily for the diagnosis and treatment of pollen-related allergies. It belongs to the class of non-standardized plant allergenic extracts.
Name
Bassia Scoparia Fruit
Raw Name
BASSIA SCOPARIA FRUIT
Category
Non-Standardized Pollen Allergenic Extract [EPC]
Drug Count
3
Variant Count
3
Last Verified
February 17, 2026
About Bassia Scoparia Fruit
Bassia Scoparia Fruit is a non-standardized allergenic extract used primarily for the diagnosis and treatment of pollen-related allergies. It belongs to the class of non-standardized plant allergenic extracts.
Detailed information about Bassia Scoparia Fruit
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Bassia Scoparia Fruit.
Bassia Scoparia Fruit, derived from the plant Bassia scoparia (formerly known as Kochia scoparia), is a complex biological substance utilized in the field of clinical immunology and allergy. In the context of modern medicine, it is classified primarily as a Non-Standardized Pollen Allergenic Extract [EPC]. This classification indicates that the extract is used to diagnose or treat allergic reactions to the pollen of the Bassia scoparia plant, which is commonly known by names such as 'Burning Bush,' 'Mexican Fireweed,' or 'Summer Cypress.'
Pharmacologically, Bassia Scoparia Fruit extracts are prepared for use in skin testing (diagnostic) and subcutaneous immunotherapy (therapeutic). As a non-standardized extract, its potency is typically measured in Protein Nitrogen Units (PNU) or Weight/Volume (W/V) ratios, rather than standardized bioequivalent units. This distinguishes it from 'standardized' extracts like those for short ragweed or certain dust mites, which have FDA-mandated potency requirements. Historically, the FDA approved these extracts under the 'Panel on Review of Allergenic Extracts' which evaluated the safety and efficacy of thousands of biological products starting in the 1970s.
In some regulatory databases, Bassia Scoparia Fruit is also associated with the drug class Adrenocorticotropic Hormone [EPC], though this is an atypical classification likely related to its historical use in traditional medicine systems where it was believed to influence metabolic or endocrine pathways. However, its primary clinical use in the United States and Europe remains centered on allergy management. Talk to your healthcare provider to understand the specific intent of your prescription.
At the molecular level, Bassia Scoparia Fruit extract works by interacting with the human immune system's Type I hypersensitivity pathway. When used for diagnostic purposes (skin prick testing), the extract contains specific allergenic proteins (antigens). When these antigens are introduced into the skin of a sensitized individual, they bind to specific Immunoglobulin E (IgE) antibodies that are already attached to the surface of mast cells and basophils. This binding triggers 'cross-linking' of the IgE receptors, leading to the immediate release of inflammatory mediators like histamine, leukotrienes, and prostaglandins. This results in a localized 'wheal and flare' reaction (a bump and redness), which allows the allergist to confirm a specific allergy to the plant.
When used for therapeutic purposes (immunotherapy or 'allergy shots'), the mechanism is more complex and involves 'immune modulation.' By administering gradually increasing doses of the Bassia Scoparia Fruit extract, the healthcare provider aims to shift the patient's immune response from a Th2-dominated allergic response to a Th1-dominated or regulatory T-cell (Treg) response. This process leads to the production of 'blocking antibodies' (IgG4), which can intercept the allergen before it reaches the IgE on mast cells, thereby reducing the severity of allergic symptoms over time.
Unlike traditional small-molecule drugs (like ibuprofen or lisinopril), allergenic extracts like Bassia Scoparia Fruit do not follow a standard pharmacokinetic path of absorption, distribution, metabolism, and excretion (ADME).
Bassia Scoparia Fruit extracts are FDA-indicated for two primary purposes:
Bassia Scoparia Fruit is typically available in the following forms:
> Important: Only your healthcare provider can determine if Bassia Scoparia Fruit is right for your specific condition. The use of this product requires specialized training in the management of allergic diseases and potential emergency reactions.
Dosage for Bassia Scoparia Fruit extract is highly individualized and must be determined by a qualified allergist or immunologist. There is no 'standard' dose because the extract is non-standardized.
Bassia Scoparia Fruit extract is used in children, but with extreme caution.
No specific dosage adjustments are provided for renal impairment, as the proteins are not primarily cleared by the kidneys. However, the patient's overall health must be stable.
No specific adjustments are required for patients with liver disease.
Older adults may be at higher risk if they have underlying cardiovascular disease. If an elderly patient is taking beta-blockers, immunotherapy may be contraindicated because these drugs can interfere with the effectiveness of epinephrine if an allergic reaction occurs.
Bassia Scoparia Fruit extract is never self-administered at home for the treatment of allergies. It must be administered in a clinical setting equipped with emergency supplies.
If you miss an immunotherapy appointment, do not attempt to 'double up' the next dose.
An 'overdose' in the context of allergenic extracts refers to receiving a dose higher than the patient's current tolerance level.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your schedule or skip doses without medical guidance, as this increases the risk of a severe reaction.
The most frequent side effects of Bassia Scoparia Fruit extract are localized to the site of the injection or skin test. These are generally expected and indicate that the immune system is recognizing the allergen.
> Warning: Stop taking Bassia Scoparia Fruit (discontinue the session) and call your doctor or emergency services immediately if you experience any of the following symptoms of Anaphylaxis:
There are no known 'toxic' long-term side effects of Bassia Scoparia Fruit extract, as it is a biological protein mixture rather than a synthetic chemical. However, the primary long-term risk is the development of new sensitivities (though rare) or the persistence of local skin changes at the frequent injection sites (such as minor scarring or thickening of the skin).
While specific 'Black Box' text varies by manufacturer, all allergenic extracts like Bassia Scoparia Fruit carry a warning regarding Anaphylaxis.
Summary of Warning: This product can cause severe, life-threatening systemic allergic reactions, including anaphylaxis. It must only be administered by healthcare providers prepared to manage such reactions. Patients with unstable asthma are at a significantly higher risk of fatal outcomes. Patients should be observed for at least 30 minutes following administration. Some patients may experience 'delayed' systemic reactions that occur after they leave the clinic.
Report any unusual symptoms, especially those occurring hours after your appointment, to your healthcare provider immediately.
Bassia Scoparia Fruit extract is a potent biological agent. It is not a 'medication' in the traditional sense but an 'immunomodulator.' Its safety depends entirely on correct administration and patient selection. Patients must be in their 'baseline' state of health on the day of injection. If you have a fever, a cold, or an active asthma flare-up, you must inform your nurse or doctor, as the injection may need to be postponed.
No FDA black box warnings for Bassia Scoparia Fruit specifically exist in the same format as synthetic drugs like antidepressants; however, the class-wide warning for Allergenic Extracts is universally applied. This warning emphasizes that these products should only be used by physicians experienced in treating allergy and that emergency equipment (epinephrine, airway management) must be immediately available. The warning also highlights that patients on beta-blockers may be resistant to the effects of epinephrine.
No routine blood tests (like liver or kidney panels) are required for Bassia Scoparia Fruit. However, the following monitoring is standard:
Bassia Scoparia Fruit generally does not cause drowsiness. However, if you experience a systemic reaction or are given antihistamines/epinephrine to treat a reaction, you should not drive or operate machinery until the symptoms and the effects of the emergency medications have fully worn off.
There is no direct interaction between alcohol and the extract. However, alcohol can cause vasodilation (widening of blood vessels), which may theoretically increase the speed of allergen absorption or worsen the flushing associated with an allergic reaction. It is best to avoid alcohol for several hours after an injection.
There is no 'withdrawal' syndrome associated with stopping Bassia Scoparia Fruit. However, if you stop immunotherapy before the recommended 3-5 year course, your allergy symptoms are likely to return to their previous severity. Discuss a tapering or completion plan with your allergist.
> Important: Discuss all your medical conditions, especially heart or lung problems, with your healthcare provider before starting Bassia Scoparia Fruit.
There are no known direct food interactions with Bassia Scoparia Fruit extract. However, patients with 'Oral Allergy Syndrome' may find that eating certain raw fruits (like melons or bananas) during the Bassia scoparia pollen season increases their overall allergic sensitivity.
Bassia Scoparia Fruit extract will directly affect the results of Allergy Skin Tests and Serum IgE (RAST/ImmunoCAP) tests. It does not typically interfere with standard blood chemistry, CBC, or urinalysis results.
For each major interaction, the mechanism is usually pharmacodynamic (affecting how the body responds to the drug) rather than pharmacokinetic (affecting drug levels). The management strategy is always to provide a full medication list to the allergist before the first dose.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter eye drops and nasal sprays.
Bassia Scoparia Fruit must NEVER be used in the following circumstances:
Patients allergic to Bassia Scoparia Fruit may also show cross-sensitivity to other members of the Chenopodiaceae family, such as Chenopodium album (Lamb’s quarters) or Salsola kali (Russian Thistle). This is due to the similarity of the proteins in the pollen. If you are allergic to one, your doctor will likely test for the others.
> Important: Your healthcare provider will evaluate your complete medical history, including heart health and lung function, before prescribing Bassia Scoparia Fruit.
FDA Pregnancy Category C. There are no adequate and well-controlled studies of Bassia Scoparia Fruit in pregnant women.
It is not known whether the components of Bassia Scoparia Fruit extract are excreted in human milk. However, since the allergens are large proteins that are processed locally by the immune system, it is highly unlikely that they would reach the breast milk in a form that would affect the nursing infant. The benefits of breastfeeding generally outweigh the theoretical risks.
In patients over 65, the decision to use Bassia Scoparia Fruit extract must be made carefully.
No dosage adjustments are needed. The proteins in the extract are broken down by cellular proteases and do not rely on renal filtration for clearance. However, patients with end-stage renal disease should be monitored for overall physiological stability.
No adjustments are required. The liver does not play a primary role in the 'metabolism' of injected allergenic proteins.
> Important: Special populations require individualized medical assessment. Always inform your allergist if your health status or medications change.
Bassia Scoparia Fruit extract functions as an immunobiological desensitizing agent. Its molecular mechanism involves the presentation of specific pollen antigens (proteins) to the immune system.
| Parameter | Value |
|---|---|
| Bioavailability | N/A (Subcutaneous/Local) |
| Protein Binding | N/A (Interacts with IgE/IgG) |
| Half-life | Variable (Proteins degraded in hours/days) |
| Tmax | 15-30 minutes (for local reaction) |
| Metabolism | Cellular Proteolysis |
| Excretion | Cellular turnover/Metabolic pathways |
Bassia Scoparia Fruit belongs to the Non-Standardized Plant Allergenic Extract class. It is related to other weed extracts like Ambrosia (Ragweed) and Salsola (Russian Thistle), though the specific protein structures are unique to the genus Bassia.
Medications containing this ingredient
Common questions about Bassia Scoparia Fruit
Bassia Scoparia Fruit extract is primarily used by allergists to diagnose and treat allergies to the pollen of the Bassia scoparia plant, also known as burning bush or Mexican fireweed. For diagnosis, it is used in skin prick tests to see if a patient develops a localized allergic reaction. For treatment, it is used in allergen immunotherapy, commonly known as 'allergy shots.' This involves giving the patient gradually increasing amounts of the extract to help their immune system become less sensitive to the pollen over time. It is specifically indicated for patients with allergic rhinitis, conjunctivitis, or asthma that is triggered by this weed.
The most common side effects are localized to the site where the extract was injected or applied. These include redness, itching, and a raised bump known as a wheal, which usually appears within minutes. Some patients may also experience 'delayed' local reactions, which involve swelling of the arm that appears several hours later. These local reactions are generally not dangerous but can be uncomfortable. Systemic symptoms like mild sneezing or a few hives are less common but require monitoring. Because it is an allergen, the most serious but rare side effect is anaphylaxis, which is why it is only given in a doctor's office.
It is generally recommended to avoid alcohol for several hours after receiving an injection of Bassia Scoparia Fruit extract. Alcohol can cause your blood vessels to dilate (expand), which might theoretically speed up the absorption of the allergen into your bloodstream, increasing the risk of a systemic reaction. Additionally, alcohol can cause flushing and may make it harder for you or your doctor to identify the early signs of an allergic reaction. While there is no direct chemical interaction between the extract and alcohol, safety precautions dictate staying 'clear-headed' and avoiding anything that alters your vascular tone after an immunotherapy session.
Bassia Scoparia Fruit is classified as FDA Pregnancy Category C, meaning there is not enough data to confirm its safety in pregnant women. Most healthcare providers will not start a new course of allergy shots during pregnancy because of the risk of anaphylaxis, which can deprive the fetus of oxygen. However, if a woman is already on a stable maintenance dose and is not having reactions, many allergists will continue the treatment to prevent a surge in allergy symptoms. You should have a detailed discussion with your allergist and obstetrician if you are planning to become pregnant or find out you are pregnant while on this treatment.
For diagnostic purposes, the extract works almost immediately, with skin test results appearing within 15 to 20 minutes. For therapeutic immunotherapy, the process is much slower and requires patience. Most patients do not notice a significant decrease in their allergy symptoms until they reach their 'maintenance dose,' which usually takes 3 to 6 months of weekly injections. Full effectiveness is typically reached after one year of consistent treatment. To achieve long-lasting results that persist even after the shots are stopped, a full course of 3 to 5 years is generally recommended by clinical guidelines.
Yes, you can stop taking Bassia Scoparia Fruit injections suddenly without experiencing any physical withdrawal symptoms, as it is not an addictive or physiologically dependent medication. However, stopping the treatment prematurely, especially during the first year or two, will likely result in the return of your original allergy symptoms. The 'desensitization' of the immune system requires consistent exposure over a long period. If you need to stop due to side effects, cost, or travel, you should discuss this with your allergist, as they may be able to adjust your schedule rather than stopping entirely.
If you miss an immunotherapy dose, you should contact your allergist's office as soon as possible to reschedule. You should never try to 'make up' for a missed dose by taking a higher amount later. The safety of immunotherapy depends on the timing of the doses; if too much time passes between injections, your sensitivity to the extract may increase. Depending on how many weeks you have missed, your doctor may need to repeat your last dose or even reduce the dose slightly to ensure you don't have a reaction when you resume treatment.
There is no clinical evidence to suggest that Bassia Scoparia Fruit extract causes weight gain. Unlike systemic corticosteroids (like prednisone), which are known to affect metabolism and appetite, allergenic extracts are biological proteins that work locally and on specific immune pathways. They do not contain hormones or calories that would contribute to weight changes. If you experience weight gain while on immunotherapy, it is likely due to other factors, such as other medications you may be taking (like certain antihistamines that can increase appetite) or unrelated lifestyle changes. Always discuss weight concerns with your primary care physician.
Bassia Scoparia Fruit can be taken alongside most common medications, but there are some very important exceptions. You must tell your doctor if you are taking beta-blockers (for blood pressure or heart conditions), as these can make it very difficult to treat a severe allergic reaction if one occurs. ACE inhibitors and certain antidepressants (MAOIs and TCAs) also require caution. Additionally, you should stop taking antihistamines several days before a diagnostic skin test, as they will block the reaction and lead to inaccurate results. Most other routine medications for cholesterol, diabetes, or thyroid issues do not interact with the extract.
The concept of 'generic' vs. 'brand name' is different for allergenic extracts than for pills. Bassia Scoparia Fruit is a biological product, and various laboratories (such as Greer, ALK, or HollisterStier) produce their own versions of the extract. While these are not 'generics' in the traditional sense, they are often considered interchangeable by allergists, provided the concentration (PNU or W/V) is carefully noted. Because it is a non-standardized biological extract, each manufacturer's product may have slight variations in the exact protein makeup, so doctors often prefer to keep a patient on the same manufacturer's extract throughout their treatment.